ClinicalTrials.gg
Sign In
Drug

Pentamidine clinical trials

Also written VLX103.

studies test it
25
open now
3
in phase 3
2
first study started
2001

How each study uses Pentamidine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Pentamidine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Oct 1984 · PENTAM · NDA 019264 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pentamidine isethionate
15
Pentamidine
7

Development codes

VLX103
2
OCZ103-OS
1

Studies by the year they started

12 studies that test it; most in 2008 (2); 1 more planned to start later

Studies that test Pentamidine, by start year
YearStudies
20011
20082
20091
20111
20121
20141
20171
20182
20262

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
7
Phase 3
2
Phase 4
1
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Pneumonia, Pneumocystis
13
Hodgkin Disease
1
Acquired Immunodeficiency Syndrome
1
Diabetes Mellitus, Type 1
1
Carcinoma, Hepatocellular
1
Carcinoma, Non-Small-Cell Lung
1
Colorectal Neoplasms
1
Pancreatic Neoplasms
1
Leishmaniasis, Cutaneous
1
Cicatrix, Hypertrophic
1
Melanoma
1
Fatty Liver
1

Who runs them

Industry 12 · Other 13

National Institute of Allergy and Infectious Diseases (NIAID) (5) · Fisons (5) · Oncozyme Pharma Inc. (4) · Institute of Tropical Medicine, Belgium (2) · LyphoMed (2) · Reinhold Munker (1) · Glaxo Wellcome (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1)

Often tested with

Tested in the same studies.

Sirolimus (1) · Tacrolimus (1) · Daclizumab (1) · Sulfamethoxazole (1) · Ganciclovir (1) · Trimethoprim (1) · Miltefosine (1) · Paromomycin (1)

Studies

Open first, then newest update. How each study uses Pentamidine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test Pentamidine →

Given beside what is tested · 2 — Pentamidine is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Pentamidine

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting1

Codes

What other systems call Pentamidine · ClinicalTrials.gg INT007972

  • MeSH (NLM) D010419PentamidineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 673LC5J4LQPENTAMIDINEConfirmed FDA, NLM, Wikidata
  • RxNorm 7994Confirmed FDA, Wikidata
  • Wikidata Q416206pentamidineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C731PentamidineOne source FDA
  • DrugBank DB00738One source Wikidata

Also registered as pentamidine diisethionate (UNII V2P3K60DA2 · RxNorm 7995) and pentamidine mesylate (UNII 863QBB4D0A).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.